PRCT
PROCEPT BIOROBOT (PRCT)
NASDAQ
$20.77+$0.39 (+1.89%)
Price as of Sep 11, 2026 7:30 PM EDT
  • $1.2B
    Market Cap
  • -45.13%
    1-Year Change
  • Medical Devices
    Industry

Key Performance

More
  • Earnings Score: N/A
  • Momentum Score: 30
  • True Yield: N/A
  • Financial Health Score: N/A
TradeSmith Loading

Latest Research & News

PRCT DEADLINE: ROSEN, REGARDED INVESTOR COUNSEL, Encourages PROCEPT BioRobotics Corporation Investors with Losses in Excess of $100K to Secure Counsel Before Important September 22 Deadline in Securities Class Action – PRCT

Rosen Law Firm is notifying investors in PROCEPT BioRobotics Corporation (NASDAQ: PRCT) of a securities class action lawsuit with a September 22, 2026 lead plaintiff deadline. The lawsuit alleges that PROCEPT made materially false statements regarding its sales practices, including use of undisclosed discount programs that artificially inflated handpiece unit sales and revenues, created excess inventory of over 10,000 units, and made unachievable 2025 guidance. Investors with losses exceeding $100,000 are encouraged to seek counsel.

09/08/2026, 9:43 PMGlobeNewswire

REMINDER: PROCEPT BioRobotics Corporation Investors With Significant Losses Must Act By September 22, 2026 - Contact Kirby McInerney LLP

Kirby McInerney LLP is reminding PROCEPT BioRobotics investors of the September 22, 2026 deadline to seek lead plaintiff status in a federal securities class action. The lawsuit alleges the company made false statements about handpiece unit sales by concealing an extensive discount program that artificially inflated revenues and created over 10,000 excess units in field inventory. Stock declined significantly following earnings misses and guidance reductions in August, November 2025, and February 2026.

09/08/2026, 8:00 PMGlobeNewswire

Deadline Alert: PROCEPT BioRobotics Corporation (PRCT) Shareholders Who Lost Money Urged To Contact Glancy Prongay Wolke & Rotter LLP About Securities Fraud Lawsuit

PROCEPT BioRobotics Corporation faces a class action securities fraud lawsuit alleging the company used an undisclosed discount program to artificially inflate handpiece sales and revenues between February 2024 and February 2026. The scheme allegedly created excess field inventory of over 10,000 units and misled investors about business performance, resulting in significant stock price declines following quarterly earnings revelations.

09/07/2026, 2:00 PMGlobeNewswire

WIX DEADLINE NOTICE: ROSEN, TOP RANKED GLOBAL COUNSEL, Encourages Wix.com Ltd. Investors with Losses in Excess of $100K to Secure Counsel Before Important Deadline in Securities Class Action – WIX

Rosen Law Firm has filed securities class action lawsuits against multiple companies. The primary case involves Wix.com Ltd., which allegedly made false statements about its AI product offerings, overstating competitiveness and understating development costs. Similar lawsuits have been filed against The Simply Good Foods Company and PROCEPT BioRobotics Corporation. Investors with losses exceeding $100K are encouraged to join before the September 22, 2026 deadline.

09/05/2026, 5:29 PMGlobeNewswire

PRCT DEADLINE ALERT: ROSEN, A LONGSTANDING LAW FIRM, Encourages PROCEPT BioRobotics Corporation Investors with Losses in Excess of $100K to Secure Counsel Before Important Deadline in Securities Class Action – PRCT

Rosen Law Firm alerts PROCEPT BioRobotics investors with losses exceeding $100K about a September 22, 2026 deadline to join a securities class action lawsuit. The lawsuit alleges PROCEPT made materially false statements regarding undisclosed discount programs that artificially inflated handpiece unit sales and revenues, created excess field inventory exceeding 10,000 units, and rendered 2025 guidance unachievable.

09/05/2026, 4:38 PMGlobeNewswire

PRCT FINAL DEADLINE: ROSEN, TRUSTED INVESTOR COUNSEL, Encourages PROCEPT BioRobotics Corporation Investors with Losses in Excess of $100K to Secure Counsel Before Important Deadline in Securities Class Action – PRCT

Rosen Law Firm is notifying PROCEPT BioRobotics Corporation investors of a securities class action lawsuit with a September 22, 2026 lead plaintiff deadline. The lawsuit alleges that PROCEPT made materially false statements regarding its discount programs, handpiece unit sales, and revenue guidance. The company allegedly used undisclosed bulk order discounts that artificially inflated sales figures and created over 10,000 excess units of field inventory, exposing the company to material operational and financial risks.

09/02/2026, 9:31 PMGlobeNewswire

BE DEADLINE: ROSEN, GLOBAL INVESTOR COUNSEL, Encourages Bloom Energy Corporation Investors with Losses in Excess of $100K to Secure Counsel Before Important Deadline in Securities Class Action - BE

Rosen Law Firm is soliciting investors who purchased securities of Bloom Energy Corporation (BE) between February 27, 2025 and July 8, 2026 to join a class action lawsuit. The lawsuit alleges that Bloom Energy made materially false and misleading statements regarding its reliance on scandium sourced from China through intermediaries, which was not properly disclosed to investors. The lead plaintiff deadline is September 28, 2026. Similar class action notices are being issued for PROCEPT BioRobotics Corporation (PRCT) and Hertz Global Holdings, Inc. (HTZ).

09/02/2026, 9:31 PMGlobeNewswire

HTZ IMPORTANT DEADLINE: ROSEN, GLOBAL INVESTOR COUNSEL, Encourages Hertz Global Holdings, Inc. Investors with Losses in Excess of $100K to Secure Counsel Before Important Deadline in Securities Class Action - HTZ

Rosen Law Firm is notifying investors in Hertz Global Holdings (HTZ), PROCEPT BioRobotics (PRCT), and Bloom Energy (BE) about securities class action lawsuits. The firm is seeking lead plaintiffs with losses exceeding $100K, with a September 22, 2026 deadline. The Hertz lawsuit alleges defendants made false statements about liquidity and market conditions, leading to a dilutive capital raise that harmed shareholders.

09/02/2026, 9:19 PMGlobeNewswire

WIX FINAL DEADLINE: ROSEN, A TOP-RANKED LAW FIRM, Encourages Wix.com Ltd. Investors with Losses in Excess of $100K to Secure Counsel Before Important Deadline in Securities Class Action – WIX

Rosen Law Firm announces securities class action lawsuits against Wix.com Ltd., PROCEPT BioRobotics Corporation, and Bloom Energy Corporation. The lawsuits allege that Wix made false statements regarding its AI product offerings, overstating competitiveness and understating development costs. Investors with losses exceeding $100,000 are encouraged to join the class actions before the September 22, 2026 deadline.

09/02/2026, 9:13 PMGlobeNewswire

PROCEPT BioRobotics Corporation Securities Fraud Class Action Result of Undisclosed Inventory Issues and approximately 18% Stock Decline - Investors may Contact Reed Kathrein at Hagens Berman Sobol Shapiro LLP

A securities class action has been filed against PROCEPT BioRobotics for allegedly withholding information about handpiece sales practices. The company allegedly used undisclosed bulk order discount programs to artificially inflate sales by pulling forward orders from future quarters, resulting in excess customer inventory exceeding 10,000 units. The stock declined approximately 48% from August 2025 to February 2026 as the company made successive downward revisions and eventually disclosed the inventory issues.

09/02/2026, 6:46 PMGlobeNewswire

Kaplan Fox Reminds Rackspace Technology, Inc. (NASDAQ: RXT) Investors to Seek a Leadership Role Before Deadline on September 28, 2026

Kaplan Fox has filed securities class action lawsuits against Rackspace Technology, Bloom Energy Corporation, and PROCEPT BioRobotics Corporation on behalf of investors who suffered losses. The Rackspace lawsuit alleges the company made false statements about its AI initiatives, Public Cloud revenue decline, and fiscal year 2026 revenue impact. Lead plaintiff deadlines range from September 22-28, 2026.

09/02/2026, 8:45 AMGlobeNewswire

INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in Photronics, Inc. of Class Action Lawsuit and Upcoming Deadlines – PLAB

Pomerantz Law Firm has filed class action lawsuits against Photronics, Inc. and PROCEPT BioRobotics Corporation, alleging securities fraud and unlawful business practices. Photronics' stock fell 36.4% on May 28, 2026, following disappointing Q2 fiscal 2026 results with revenue and earnings below projections and an 11% sequential decline in IC revenue. The deadline to join the Photronics class action as Lead Plaintiff is September 4, 2026.

09/01/2026, 4:56 PMGlobeNewswire

INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in PROCEPT BioRobotics Corporation of Class Action Lawsuit and Upcoming Deadlines – PRCT

Pomerantz Law Firm has filed a class action lawsuit against PROCEPT BioRobotics Corporation, alleging securities fraud and unlawful business practices. The lawsuit stems from the company's repeated mismanagement of inventory and missed sales guidance. PROCEPT failed to disclose that handpiece sales significantly exceeded procedures, resulting in over 10,000 units of excess field inventory. The company's stock declined sharply following three earnings announcements in 2025-2026, with the most recent showing a 30% sequential decline in quarterly handpiece sales. Investors have until September 22, 2026, to request Lead Plaintiff status.

09/01/2026, 4:50 PMGlobeNewswire

Portnoy Law Firm Announces Class Action on Behalf of PROCEPT BioRobotics Corporation Investors

A class action lawsuit has been filed against PROCEPT BioRobotics Corporation for allegedly making materially false and misleading statements regarding its business operations. The company allegedly used undisclosed discount programs that artificially inflated handpiece unit sales and revenues, created excess field inventory of over 10,000 units, and failed to disclose risks that prevented it from achieving 2025 guidance. Stock prices fell significantly following earnings announcements in August, November 2025, and February 2026 that revealed lower-than-expected sales and inventory management issues.

09/01/2026, 3:59 PMGlobeNewswire

Deadline Alert: PROCEPT BioRobotics Corporation (PRCT) Shareholders Who Lost Money Urged To Contact Glancy Prongay Wolke & Rotter LLP About Securities Fraud Lawsuit

A class action lawsuit has been filed against PROCEPT BioRobotics Corporation for allegedly making materially false statements about its business between February 2024 and February 2026. The company allegedly used an undisclosed discount program to artificially inflate handpiece sales, creating excess inventory of over 10,000 units. Stock prices fell significantly following three earnings announcements revealing lower-than-expected sales and inventory issues. Shareholders have until September 22, 2026 to file lead plaintiff motions.

08/31/2026, 2:30 PMGlobeNewswire

Peers

Statistics

More
Day Range
$19.55
$20.67
$20.38
1-Year Range
$16.69
$39.57
$20.38
Latest Close$20.38
Change
+$0.31 (+1.52%)
Volume1,573,244
Market Cap$1.2B
Shares Outstanding57.3M
P/E (TTM)-10.46
Diluted EPS (TTM)-$1.95
Enterprise Value$991.0M

Information as of 09/11/2026

Company Profile

PROCEPT BIOROBOTICS CORP
PROCEPT BIOROBOTICS CORP
https://www.procept-biorobotics.com
$1.2B
Market Cap
-$109.8M
Net Income
Sector: Healthcare
Industry: Medical Devices
150 Baytech Drive, San Jose, CA, United States, 95134
650 232 7200

PROCEPT BioRobotics Corporation, a surgical robotics company, develops transformative solutions in urology in the United States and internationally. It develops, manufactures, and sells AquaBeam Robotic System, an image-guided, surgical robotic system for use in minimally invasive urologic surgery focusing on treating benign prostatic hyperplasia. The company also provides HYDROS Robotic System, which provides Aquablation therapy image-guided robotic therapy to treat males suffering from lower urinary tract symptoms due to benign prostatic hyperplasia. PROCEPT BioRobotics Corporation was incorporated in 2007 and is headquartered in San Jose, California.

Key Executives

  • Larry L. Wood
  • Kevin Waters
  • Alaleh Nouri
  • Matthew James Bacso
  • Stephen J. McGill

Current Ownership Distribution

  • Institutions855.3M (75.14%)
  • Mutual Funds253.2M (22.25%)
  • Insiders29.7M (2.61%)
  • Other0 (0.00%)